hyperplasia of prostate
Conditions
Interventions
Experimental group:New laser enucleation of the prostate
Experimental group:Risk factor-based proactive intervention programs and normal treatment tailored to the Chinese population
Experimental group:Transcutaneous electrical nerve stimulation was used on the basis of conventional rehabilitation measures
Control group :Routine rehabilitation measures
Sponsors
Chinese PLA General Hospital
Eligibility
Sex/Gender
Male
Inclusion criteria
Inclusion criteria: 1. Entry requirements: male >=40 years old; International Prostate Symptom Scale (IPSS), score >=8 points; 2. Withdrawal/Early Discontinuation of Study: Patients who discontinue the study prior to completion of the evaluation specified in the study protocol are considered to have withdrawn/stopped the study early. Patients may withdraw/discontinue the study early for any of the following reasons: adverse events (AE);Serious complications. The final evaluation of the patient should take place at this time and the early discontinuation of the study should be documented on the appropriate page of the case report form. Patients who withdraw due to adverse events will be followed up by the investigator.
Exclusion criteria
Exclusion criteria: Poor general condition; Serum PSA increased; Blood disease; Propensity to bleed; Drug addiction (including drug, narcotic and alcohol addiction); Has the psychological spirit disease, cannot cooperate with the rehabilitation treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| acid phosphatase;nuclear matrix proteins 22;fibrin fibrinogen degradation products;Lipoprotein-associated phospholipaseA2;prostatic acid phosphatase;complex edprostate specific antigen;Prostate specific antigen;free prostate special antigen;maximum urinary flow rate;post-voiding residual; | — |
Countries
China
Contacts
Public ContactTian Yaping
Chinese PLA General Hospital
Outcome results
None listed